Sign In
Buy ACON
$3.49
-0.0100 (-0.286%)
At Close: Jun 03, 2026
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan
09:25am, Thursday, 19'th Mar 2026
BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (Nasdaq: ACON, ACONW) (“Aclarion” or the “Company”) today announced that its Board of Directors (the “Board”) has unani
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts
06:00am, Thursday, 19'th Mar 2026
Pursuing reimbursement coverage from one or more regional insurance providers in the United States as an important step toward broader payer adoption Initial CLARITY trial readout in Q4 2026 Strong Ba
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts
06:00am, Thursday, 19'th Mar 2026
Pursuing reimbursement coverage from one or more regional insurance providers in the United States as an important step toward broader payer adoption Initial CLARITY trial readout in Q4 2026 Strong Ba
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet
06:23am, Tuesday, 17'th Mar 2026
Broomfield, CO, March 17, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution)– Aclarion, Inc.
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet
06:00am, Tuesday, 17'th Mar 2026
BROOMFIELD, Colo., March 17, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging
Aclarion CEO Brent Ness to Attend LSI USA 2026
10:32am, Thursday, 12'th Mar 2026
Broomfield, CO, March 12, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-
Aclarion CEO Brent Ness to Attend LSI USA 2026
06:00am, Thursday, 12'th Mar 2026
BROOMFIELD, Colo., March 12, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging
NeuroOne Medical Technologies (NASDAQ:NMTC) versus Aclarion (NASDAQ:ACON) Head to Head Contrast
02:59am, Thursday, 12'th Feb 2026
Aclarion (NASDAQ: ACON - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the
Aclarion (NASDAQ:ACON) & InnovAge (NASDAQ:INNV) Head-To-Head Comparison
01:46am, Tuesday, 10'th Feb 2026
Aclarion (NASDAQ: ACON - Get Free Report) and InnovAge (NASDAQ: INNV - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies bas
Aclarion Publishes 2026 Shareholder Letter from the Chairman
06:01am, Thursday, 05'th Feb 2026
Broomfield, CO, February 5, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc.
Aclarion Publishes 2026 Shareholder Letter from the Chairman
06:00am, Thursday, 05'th Feb 2026
Company anticipates no capital raises prior to expected value enhancing catalysts Cash runway into 2028 ATM terminated in early 2025 and ELOC expired December 31, 2025 BROOMFIELD, Colo., Feb. 05, 20
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation
06:00am, Tuesday, 03'rd Feb 2026
Broomfield, CO, February 03, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commerci
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation
06:00am, Tuesday, 03'rd Feb 2026
Expands availability of Nociscan in the greater Los Angeles area Reinforces Nociscan's non-invasive advantage with real-world clinical validation compared to anesthetic discography, a spinal injection
Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028
06:00am, Tuesday, 13'th Jan 2026
Debt-Free Balance Sheet With $21.6 Million in Cash BROOMFIELD, Colo., Jan. 13, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc.
Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028
06:00am, Tuesday, 13'th Jan 2026
BROOMFIELD, Colo., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging bi
